RNA Therapeutics
Part of Healthcare - Genomics & Precision Medicine
| Ticker | Company | Mkt Cap▼ | Price | Chg% | Volume |
|---|---|---|---|---|---|
 ALNY | Alnylam Pharmaceuticals, Inc. | $41.9b | $305.65 | -2.6% | 825.6K |
 IONS | Ionis Pharmaceuticals, Inc. Common Stock | $12.0b | $73.24 | -1.1% | 1.8M |
 ARWR | Arrowhead Research Corporation | $8.1b | $73.93 | -0.6% | 1.6M |
 WVE | Wave Life Sciences Ltd. Ordinary Shares | $1.2b | $7.18 | -1.8% | 2.8M |
 RNA | Atrium Therapeutics, Inc. Common Stock | $210.2m | $13.50 | -2.5% | 196.6K |
 CAMP | CAMP4 Therapeutics Corporation Common Stock | $207.7m | $4.43 | -0.2% | 85.7K |
 PRQR | ProQR Therapeutics N.V. Ordinary Shares | $159.1m | $1.54 | -5.5% | 1.2M |
 RNAC | Cartesian Therapeutics, Inc. Common Stock | $155.9m | $6.74 | -3.3% | 118.9K |
 XCUR | Exicure, Inc. Common Stock | $28.5m | $3.59 | -1.4% | 19.9K |
 PHIO | Phio Pharmaceuticals Corp. Common Stock | $13.9m | $1.20 | -2.9% | 230.5K |